Whitepaper · July 28, 2025
Tools and Processes for Medical Device Cybersecurity: FDA Premarket Guidance Explained
Discover essential tools and processes for medical device cybersecurity compliance. This paper proposes a hypothetical vendor's mature program, analyzing how it meets FDA Premarket and Postmarket Guidance to ensure "secure by design" devices.
Executive summary
What this whitepaper covers
The FDA’s 2022 update to its Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions guidance signaled a clear shift: cybersecurity is no longer an afterthought, it’s a core quality requirement. This whitepaper explores the tools and processes necessary for medical device manufacturers (MDMs) to meet these expectations. It introduces the FDA’s secure product development framework (SPDF), maps guidance requirements to specific actions, and highlights how Medcrypt’s technology portfolio helps manufacturers address key areas like cryptography, vulnerability management, device monitoring, and postmarket security.
Why it matters
The regulatory and product context
- R&D leaders and engineering managers building connected medical devices
- Quality and regulatory affairs professionals responsible for 510(k), PMA, or De Novo submissions
- CISOs, product security leaders, and risk managers developing SPDF programs
- Executives seeking to balance cost, compliance, and innovation in product design
Key insights
What you’ll take away
- The FDA’s premarket guidance links cybersecurity directly to device safety and effectiveness.
- Manufacturers must document processes and tools that address risk, resilience, and transparency.
- Early investment in security architecture reduces postmarket cost and compliance burden.
- Medcrypt’s solutions directly support SPDF implementation through cryptography, SBOM management, and device monitoring.
- A build–buy–partner strategy accelerates compliance while maintaining design flexibility.
Who should read this
- R&D leaders and engineering managers building connected medical devices
- Quality and regulatory affairs professionals responsible for 510(k), PMA, or De Novo submissions
- CISOs, product security leaders, and risk managers developing SPDF programs
- Executives seeking to balance cost, compliance, and innovation in product design
